Our helpline will be

closed

on Tuesday 10 November 2026

Our latest

News

Browse categories

Pancreatic Enzyme Replacement Therapy (PERT) Update 

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. We explain what manufacturers, the NHS and the Department of Health are doing, and where to turn for help.

Published: 3 weeks ago

By Leanne Talbot

Published: 3 weeks ago

By Leanne Talbot

Brexit: Warning over cancer treatment supplies after no deal

Senior doctors have called for ''urgent clarification" of plans to supply cancer treatments in the event of a no-deal Brexit, BBC Newsnight has learned.…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

Recognising the Need to Support Patients with Cancer Fatigue

Cancer related fatigue can be a major problem. The Untire app gives cancer patients and survivors the tools to help reduce fatigue.   Untire helps you get…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

Resection of the Primary Tumor Improves Survival in Patients with Gastro-Entero-Pancreatic Neuroendocrine Neoplasms with Liver Metastases

GEP‐NEN patients with liver metastases (LM) were selected from the Surveillance, Epidemiology, and End Results database between 2010 and 2015. Resection…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

NETs for Newcomers: An Introduction to NET Medicine

NETs for Newcomers 2019 is now open for registration. This one-day course is for trainee doctors and consultants in all disciplines wishing to gain…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

Exploring a New Targeted Therapy

At the 2019  meeting of the American Cancer Society of Clinical Oncologists (ASCO), Emily Bergsland, MD, University of California, San Francisco, reported…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

Radionuclide therapy effective in high-grade neuroendocrine neoplasms

Peptide receptor radionuclide therapy (PRRT) has been shown to be safe and effective for patients with grade 3 (G3) neuroendocrine neoplasms (NENs),…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

Getting a better deal for people with rare and less common cancers

With nearly half of new diagnoses, and over half of cancer deaths being from rare or less common cancers, improving care and support for people with rare…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

Cancer52/PHE Event: Development in Data for Rare and Less Common Cancers

On the 22nd May, Cancer52 and PHE/NCRAS held an event focussed on the Developments in Data for Rare and Less Common Cancers. Tracey Genus presented NPF…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot

How to survive the fake news about cancer

For Eileen O’Sullivan, being diagnosed with breast cancer in 2013 was the catalyst for a deluge of distinctly unscientific and frequently dangerous…

Published: 7 years ago

By Leanne Talbot

Published: 7 years ago

By Leanne Talbot
Load more articles